Bank of America Raises Integer (NYSE:ITGR) Price Target to $145.00

Integer (NYSE:ITGR) had its target price upped by Bank of America from $135.00 to $145.00 in a research report sent to investors on Tuesday morning, Benzinga reports. The firm currently has a buy rating on the medical equipment provider’s stock.

Several other equities analysts have also weighed in on the stock. Benchmark restated a buy rating and set a $130.00 price target on shares of Integer in a research report on Friday, August 2nd. Truist Financial increased their price target on shares of Integer from $137.00 to $145.00 and gave the company a buy rating in a research report on Tuesday. Finally, Oppenheimer assumed coverage on shares of Integer in a research report on Tuesday, July 16th. They set an outperform rating and a $135.00 price target for the company. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of Moderate Buy and an average target price of $137.29.

Integer Stock Performance

NYSE ITGR opened at $129.11 on Tuesday. Integer has a 1 year low of $69.40 and a 1 year high of $131.87. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96. The firm has a market cap of $4.33 billion, a price-to-earnings ratio of 44.67, a PEG ratio of 1.87 and a beta of 1.08. The company has a fifty day moving average price of $123.88 and a 200-day moving average price of $119.52.

Integer (NYSE:ITGR) last posted its earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.06. The firm had revenue of $436.20 million during the quarter, compared to analyst estimates of $437.00 million. Integer had a net margin of 6.31% and a return on equity of 11.48%. The business’s revenue was up 9.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.14 EPS. As a group, equities research analysts predict that Integer will post 5.31 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Jean M. Hobby sold 11,960 shares of the stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total value of $1,431,133.60. Following the sale, the director now directly owns 2,280 shares of the company’s stock, valued at approximately $272,824.80. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Integer

A number of institutional investors and hedge funds have recently modified their holdings of ITGR. Campbell & CO Investment Adviser LLC lifted its holdings in shares of Integer by 345.9% in the fourth quarter. Campbell & CO Investment Adviser LLC now owns 11,900 shares of the medical equipment provider’s stock worth $1,179,000 after buying an additional 9,231 shares in the last quarter. Public Employees Retirement Association of Colorado raised its stake in Integer by 3,260.1% in the fourth quarter. Public Employees Retirement Association of Colorado now owns 285,439 shares of the medical equipment provider’s stock valued at $28,281,000 after purchasing an additional 276,944 shares in the last quarter. Congress Asset Management Co. MA raised its stake in Integer by 12.5% in the fourth quarter. Congress Asset Management Co. MA now owns 421,524 shares of the medical equipment provider’s stock valued at $41,765,000 after purchasing an additional 46,776 shares in the last quarter. Quadrature Capital Ltd purchased a new stake in Integer in the fourth quarter valued at approximately $378,000. Finally, HighPoint Advisor Group LLC purchased a new stake in Integer in the fourth quarter valued at approximately $221,000. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.